Strides Pharma Science has informed that Strides Pharma Global (‘SPG’), a step-down wholly-owned subsidiary of the Company in Singapore, proposes to create a platform that shall foster introductions, collaborations, procurement and business engagement between pharmaceutical manufacturers and suppliers of India, China, and other Southeast-Asian countries. In this regard, it is proposed to acquire 100% stake in Amexel, Singapore, which will be utilized as the entity for the above business platform. Disclosure under Regulation 30 of SEBI Listing Regulations for the said acquisition is enclosed.
The above information is a part of company’s filings submitted to BSE.
